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ABSTRACT
The p75
NTR (where NTR is neurotrophin receptor) can
mediate many distinct cellular functions, including cell
survival and apoptosis, axonal growth and cell proliferation,
depending on the cellular context. This multifunctional
receptor is widely expressed in the CNS (central nervous
system) during development, but its expression is restricted
in the adult brain. However, p75
NTR is induced by a variety of
pathophysiological insults, including seizures, lesions and
degenerative disease. We have demonstrated previously that
p75
NTR is induced by seizures in neurons, where it induces
apoptosis, and in astrocytes, where it may regulate
proliferation. In the present study, we have investigated
whether the inflammatory cytokines IL (interleukin)-1b and
TNF-a (tumour necrosis factor-a), that are commonly
elevated in these pathological conditions, mediate the
regulation of p75
NTR in neurons and astrocytes. We have
further analysed the signal transduction pathways by which
these cytokinesinduce p75
NTRexpressionin the different cell
types, specifically investigating the roles of the NF-kB
(nuclear factor kB) and p38 MAPK (mitogen-activated
protein kinase) pathways. We have demonstrated that both
cytokines regulate p75
NTR expression; however, the mechan-
isms governing this regulation are cytokine- and cell-type
specific. The distinct mechanisms of cytokine-mediated
p75
NTR regulation that we demonstrate in the present study
may facilitate therapeutic intervention in regulation of this
receptor in a cell-selective manner.
Key words: neurotrophin receptor, nuclear factor kB (NF-
kB), p38 mitogen-activated protein kinase (p38 MAPK).
INTRODUCTION
The p75
NTR (where NTR is neurotrophin receptor) is known to
play multiple roles in regulating neuronal survival, death and
axonal growth (Greene and Rukenstein, 1981; Rabizadeh et
al., 1993; Frade et al., 1996; Maggirwar et al., 1998; Friedman,
2000). p75
NTR is more widely expressed during development
than in adults (Yan and Johnson, 1988; Friedman, 2000).
However, this receptor is re-expressed in several pathological
conditions such as traumatic brain injury, seizure, ischaemia,
oxidative stress and axonal injury (Kokaia et al., 1998; Roux et
al., 1999; Casha et al., 2001; Ramos et al., 2007). The role of
p75
NTR in these pathological conditions has been proposed to
be involved in neurodegeneration. For example, pilocarpine-
induced seizures induces p75
NTR up-regulation in the
hippocampus (Roux et al., 1999) and mediates neuronal
apoptosis by activating the caspase 9,6,3 cascade (Troy et al.,
2002). These studies suggest that there is a tight correlation
between p75
NTR expression after injury and neurodegenera-
tion. Although there are many studies demonstrating that
p75
NTR is up-regulated in pathological conditions, the
mechanisms regulating p75
NTR expression after injury are
not well defined.
IL-1b (interleukin-1b) and TNF-a (tumour necrosis factor-
a) are essential pro-inflammatory cytokines released from
several cell types, including astrocytes and microglia, after
brain injury (Giulian et al., 1986). IL-1b and TNF-a have
several physiological functions in neuroinflammation. In
particular, IL-1b is known to induce production of other
cytokines and growth factors (Benveniste, 1992; Merrill and
Benveniste, 1996), change blood flow (Monroy et al., 2001;
Maher et al., 2003) and affect neuroendocrine responses and
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asnneuro.org / Volume 1 (2) / art:e00010 113the activity of the HPA (hypothalamic–pituitary–adrenal) axis
(Berkenbosch et al., 1987; Sapolsky et al., 1987). In addition,
both IL-1b and TNF-a have direct influences on neuro-
degeneration (Zhao et al., 2001; Thornton et al., 2006), and
inhibition of endogenous IL-1b or TNF-a protects against
neuronal injury that occurs after cerebral ischaemia (Relton
and Rothwell, 1992; Meistrell et al., 1997). In addition to
effects on neurodegeneration, IL-1b also affects remyelina-
tion by oligodendrocytes after injury (Mason et al., 2001).
These cytokines are highly expressed in Alzheimer’s disease
(Griffin et al., 1989; Fillit et al., 1991; Wang et al., 1997),
Parkinson’s disease (Mogi et al., 1994, 1996) and spinal cord
injury (Wang et al., 1997; Xu et al., 1998), conditions in which
p75
NTR is induced. IL-1b and TNF-a are up-regulated within
2 h after several types of injury (Minami et al., 1992; Taupin
et al., 1993; Buttini et al., 1994; Fan et al., 1996; Eriksson et
al., 2000), but p75
NTR induction after seizure takes 24 h (Roux
et al., 1999). Therefore cytokine induction precedes p75
NTR
induction after damage, and may play a role in regulation of
p75
NTR expression. Indeed, results from microarray analysis on
astrocytes after IL-1b treatment showed increased p75
NTR
mRNA (John et al., 2005).
In the present study, we demonstrate that the pro-
inflammatory cytokines IL-1b and TNF-a up-regulate p75
NTR
in hippocampal neurons and astrocytes. However, the
underlying signalling mechanisms to induce p75
NTR are
different with distinct cytokines and cell types, suggesting
a diverse mechanism of regulating cell-specific p75
NTR
expression after injury.
MATERIAL AND METHODS
Materials
IL-1b was generously provided by Dr Ronald Hart
(Department of Cell Biology and Neuroscience, Rutgers
University, Piscataway, NJ, U.S.A.). TNF-a was purchased from
R&D systems. SB203580 and SN-50 were obtained from
Alexis Biochemicals. Eagle’s MEM (minimal essential medium),
Ham’s F12 and penicillin/streptomycin were purchased from
Invitrogen. All other materials were obtained from Sigma.
Neuronal cultures
Neuronal cultures were prepared as described previously
(Farinelli et al., 1998; Friedman, 2000). Rat hippocampi were
dissected from embryonic day 18, dissociated, plated on to
poly-D-lysine (0.1 mg/ml)-coated dishes, and maintained in
serum-free medium. The medium consisted of a 1:1 mixture
of Eagle’s MEM and Ham’s F12 supplemented with glucose (6
mg/ml), putrescine (60 mM), progesterone (20 nM), transferrin
(100 mg/ml), selenium (30 nM), penicillin (0.5 units/ml) and
streptomycin (0.5 mg/ml). Cultures were maintained in 5%
CO2 at 37˚C for 5 days before treatment. All animal studies
were conducted using the NIH (National Institutes of Health)
guidelines for the ethical treatment of animals with approval
of the Rutgers Institutional Animal Care and Use Committee.
Astrocyte cultures
Astrocyte cultures were prepared as described previously
(Srinivasan et al., 2004). Rat hippocampi were dissected from
embryonic day 21, dissociated, plated on to poly-D-lysine (0.1
mg/ml)-coated flasks, and maintained in Eagle’s MEM with
Earle’s salts, 2 mM L-glutamine, 15% heat-inactivated fetal
bovine serum, 6 mg/ml glucose, penicillin (0.5 units/ml), and
streptomycin (0.5 mg/ml). After 7–9 days incubation in 5%
CO2 at 37˚C, cells were shaken at 450 rev./min for 10 min to
remove microglia and neurons, followed by a fresh medium
change. Cells were shaken at 225 rev./min overnight to
eliminate additional non-astrocytic cells. Cells were replen-
ished with fresh medium containing 0.1 mM cytosine
arabinoside and maintained for 3 days. Trypsinized and
replated cells were kept in 5% CO2 at 37˚C for 4 days before
treatment (McCarthy and de Vellis, 1980).
Immunoprecipitation and Western blot
analysis
Cells were lysed in RIPA buffer [50 mM Tris/HCl (pH 7.5), 150
mM NaCl, 5 mM EDTA, 1% Nonidet P40, 0.5% deoxycholic
acid and 0.5% SDS] supplemented with a protease inhibitor
mixture (Roche Products), 1 mM sodium vanadate and 5 mM
sodium fluoride. Proteins were quantified using the Bradford
assay (Bio-Rad) and equal amounts of protein were run on a
10% polyacrylamide gel and transferred on to a nitrocellulose
membrane. Membranes were blocked in 5% (w/v) non-fat
dried skimmed milk in TBST [TBS (Tris-buffered saline; 10 mM
Tris and 150 mM NaCI, pH 7.4) containing 0.05% Tween 20]
and then probed with antibodies against p75
NTR (Upstate
Biotechnology), actin (Sigma), p-p38 [phosphorylated-p38
MAPK (mitogen-activated protein kinase)], p-IkB {phos-
phorylated-IkB [inhibitor of NF-kB (nuclear factor kB)]; Cell
Signaling Technology}. p-p38 and p-IkB blots were stripped
and reprobed with anti-p38 and anti-IkB (Cell Signaling
Technology) antibodies respectively. Bands were visualized by
X-ray film exposure using ECL (enhanced chemiluminescence;
Pierce). For IkB ubiquitination studies, cells were treated with
IL-1b or TNF-a for the indicated periods, then lysed in buffer
[50 mM Tris/HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 5 mM
NaF, 1 mM Na3VO4, 1% Triton X-100 and protease inhibitors],
and centrifuged (20817 g for 15 min at 4˚C). Supernatants
were incubated with anti-IkB antibody overnight at 4˚C and
then incubated with Protein A–agarose at 4˚C for 2 h.
Immunoprecipitates were washed three times with lysis
buffer and analysed by Western blot for ubiquitin (Santa
Cruz Biotechnology). Blots were scanned and quantified using
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Biotinylation of cell-surface proteins
Cells were treated with IL-1b or TNF-a for 8 h and washed
with pre-chilled PBS once, and with PBS
++ (PBS containing
1 mM MgCl2 and 2.5 mM CaCl2) twice. Cell-surface proteins
were biotinylated with sulfo-NHS-SS-Biotin (Pierce) at 4˚C
for 1 h, quenched with glycine, and washed with PBS
++ twice.
Biotinylated cells were lysed in buffer containing 50 mM Tris,
150 mM NaCl, 1 mM EDTA, 1% Nonidet P40, 0.5%
deoxycholate, protease inhibitor mixture, 1 mM sodium
vanadate and 5 mM sodium fluoride, and lysates were
incubated with streptavidin–agarose (Pierce) overnight at
4˚C. After centrifugation (4500 g for 3 min at 4˚C), super-
natants were saved and pellets were washed with lysis buffer
three times. Pellets and supernatants were analysed by
Western blot for p75
NTR and actin.
Immunostaining
To visualize nuclear translocation of NF-kB, cells were plated
on plastic Lab-Tek slide wells and treated with IL-1b or TNF-a
with or without pre-incubation with SN-50 for 30 min. Cells
were fixed in 4% (w/v) paraformaldehyde, washed with PBS,
permeabilized with PBS plus 0.3% Triton X-100, blocked in
5% (v/v) goat serum, and then incubated with anti-p65
antibody (Santa Cruz Biotechnology) overnight at 4˚C. Slides
were washed three times with PBS, incubated with secondary
antibodies coupled to the Alexa FluorH 555 fluophore
(Molecular Probes) for 1 h at room temperature (25˚C), then
washed with PBS three times. Hoechst 33342 (1 mg/ml;
Sigma) was used to visualize the nuclei.
Quantitative real-time RT (reverse
transcriptase)–PCR
Primary hippocampal neurons or astrocytes were treated
with IL-1b or TNF-a for 2, 4 or 8 h, and mRNA was isolated
using TRIzolH reagent (Invitrogen). cDNA was generated using
SuperScript
TM II RT with random hexamers (Invitrogen), and
SYBR-green-based quantitative real-time PCR was performed
using primers specific for p75
NTR (rat, forward 59-
CTGATGCTGAATGCGAAGAG-39 and reverse 59-TCACCA
TATCCGCCACTGTA-39) or actin (forward 59-TCATGAAGTGTGAC
GTTGACATCCGT-39 and reverse 59-CTTAGAAGCATTTGCG
GTGCACGATG-39) with the comparative CT method (DDCT)
(ABI).
RESULTS
To investigate whether pro-inflammatory cytokines such as
IL-1b and TNF-a induce p75
NTR in different cell types,
cultured hippocampal neurons and astrocytes were treated
with IL-1b or TNF-a f o r1 ,4 ,8 ,1 2o r2 4h .L e v e l so fp 7 5
NTR
protein were evaluated by Western blot analysis, and mRNA
was determined by quantitative PCR. The expression of
p75
NTR was increased by IL-1b and TNF-a in both neurons
and astrocytes relative to actin (Figure 1). Elevated p75
NTR
mRNA expression peaked after 4 h of treatment, and the
protein increase was maximal after 8 h of treatment with
cytokines.
Mechanisms of IL-1b regulation of p75
NTR
In our previous studies, we have demonstrated that IL-1b
activates distinct signalling pathways in neurons and
astrocytes. IL-1b activates the classical NF-kB pathway
in astrocytes but not in neurons, whereas p38 MAPK [but
not JNK (c-Jun N-terminal kinase) or ERK (extracellular-
signal-regulated kinase) MAPK] is activated by IL-1b in
hippocampal neurons (Srinivasan et al., 2004). Therefore we
investigated the underlying signalling mechanisms governing
IL-1b regulation of p75
NTR in both cell types.
We first confirmed the activation of specific signalling
pathways in the different cell types. IL-1b induced robust
transient phosphorylation of p38 MAPK in hippocampal
neurons (Figure 2A). Activation of NF-kB signalling was
monitored by phosphorylation and degradation of IkB, which
is necessary for nuclear translocation of NF-kB. In neurons,
no IkB phoshorylation was detected (results not shown),
consistent with our previous study showing that IL-1b does
not activate NF-kB in hippocampal neurons (Srinivasan et al.,
2004). However, in astrocytes there was robust increase in
p-IkB 5 min after IL-1b treatment, with a subsequent loss of
IkB protein (Figure 2B). Interestingly, IL-1b also activated p38
MAPK signalling in astrocytes, p-p38 MAPK increased within
5 min after IL-1b treatment and peaked at 10 min in
astrocytes (Figure 2C). Thus IL-1b activates both NF-kB and
p38 MAPK signalling in astrocytes, but only p38 MAPK in
hippocampal neurons.
We next examined which signalling pathway was
responsible for the IL-1b-mediated p75
NTR up-regulation in
the different cell types. Neurons or astrocytes were
pretreated either with a p38 MAPK inhibitor SB203580 (10
mM) or an NF-kB inhibitor SN-50 (10 mM) for 30 min. IL-1b
was then applied to the cells for 8 h, and p75
NTR levels were
analysed by Western blot. In hippocampal neurons, the p38
MAPK inhibitor prevented the IL-1b-mediated p75
NTR up-
regulation (Figures 3A and 3B). As expected, the NF-kB
inhibitor SN-50 did not prevent the p75
NTR expression in
neurons. In astrocytes, both the p38 MAPK inhibitor and the
NF-kB inhibitor completely prevented the IL-1b induction
of p75
NTR expression (Figures 3C and 3D), indicating that
p75
NTR induction in astrocytes requires both the p38 MAPK
and NF-kB pathways. Confirmation that the inhibitors
blocked the relevant signalling pathways is shown in
Supplementary Figure S1 (at http://www.asnneuro.org/an/
001/an001e010add.htm).
Inflammatory cytokines regulate p75
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115Figure 1 IL-1b and TNF-a induce p75
NTR in neurons and astrocytes
(A–D) Cultured hippocampal neurons were treated with either (A) IL-1b (10 ng/ml) or (B)T N F - a (10 ng/ml) for 4, 8, 12 or 24 h, and
were then lysed and analysed by Western blot for p75
NTR and actin. (C) and (D) Quantification of blots from three experiments as in
(A) and (B) respectively. Densitometric values were normalized to actin and are expressed relative to the untreated cells (time 0).
(E–H) Cultured hippocampal astrocytes were treated with either (E) IL-1b (10 ng/ml) or (F)T N F - a (10 ng/ml) for 1, 4, 8, 12 or 24 h,
and were then lysed and analysed by Western blot for p75
NTR and actin. (G) and (H) Quantification of blots from three experiments as
in (E) and (F) respectively. Densitometric values were normalized to actin and are expressed relative to the untreated cells (time 0).
(I and J) Quantitative real-time PCR analysis of p75
NTR mRNA in hippocampal neurons (I) or astrocytes (J) treated with IL-1b or TNF-a
expressed relative to untreated control cultures. The significance was determined by ANOVA with Tukey’s post-hoc analysis.
* indicates values significantly different from control at P,0.05.
S Choi and WJ Friedman
116 E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.Mechanisms of TNF-a regulation of p75
NTR
Both IL-1b and TNF-a elicited increased p75
NTR expression in
hippocampal neurons; however, the signalling mechanisms
activated by these cytokines were distinct. In contrast with
the effects of IL-1b, TNF-a elicited a modest transient
phosphorylation of IkB (Figures 4A and 4C), but failed to
induce activation of p38 MAPK (Figures 4B and 4D).
Moreover, p65 staining in nuclei was visible with TNF-a-
treated neurons, but not with IL-1b-treated neurons
(Figure 4E), confirming activation of the NF-kB pathway by
TNF-a in neurons.
In astrocytes, TNF-a treatment induced phophorylation of
IkB, which peaked at 10 min (Figure 4F) and decreased
afterwards. IkB protein was degraded after phosphorylation
(Figure 4F). TNF-a also activated the p38 MAPK pathway in
astrocytes, inducing robust phosphorylation that peaked at
10–20 min after treatment (Figure 4G). Thus TNF-a, like IL-
1b, induced activation of both the NF-kB and p38 MAPK
pathways in hippocampal astrocytes.
Interestingly, although TNF-a induced phosphorylation of
IkB in both hippocampal neurons and astrocytes, loss of IkB
protein was only observed in astrocytes (Figure 4F), not in
neurons (Figure 4A). Once IkB is phosphorylated, it goes
through polyubiquitination and proteosome-dependent
degradation (Karin and Ben-Neriah, 2000). Therefore we
investigated whether the ubiquitination of IkB occurred in
neurons. Astrocytes and neurons were treated with TNF-a for
the indicated times and the cell lysates were immunopreci-
pitated with anti-IkB antibody, and Western blot analysis was
used to detect ubiquitination. There was increased ubiquiti-
nated IkB in the TNF-a-treated astrocytes; however, no
ubiquitination was detected in neurons treated with TNF-a
(Figure 4H), consistent with the lack of IkB degradation.
TNF-a induced phosphorylation of IkB and nuclear
translocation of NF-kB in hippocampal neurons, suggesting
that the increase in p75
NTR expression induced by this
cytokine might be mediated by NF-kB. Treatment of the
neurons with the NF-kB inhibitor SN50, but not the p38
MAPK inhibitor SB203580, prevented the TNF-a-evoked
increase in p75
NTR (Figures 5A and 5B), demonstrating that
TNF-a regulates p75
NTR expression via NF-kB signalling,
whereas IL-1b regulates p75
NTR via p38 MAPK signalling in
hippocampal neurons (Figure 3).
Similar to the effects in neurons, the p38 MAPK inhibitor
did not prevent the TNF-a-mediated p75
NTR up-regulation in
astrocytes (Figures 5C and 5D), whereas NF-kB inhibition
blocked TNF-a-mediated p75
NTR expression (Figures 5C and
5D). Confirmation that the inhibitors blocked their respective
signalling pathways is shown in Supplementary Figure S1.
Thus, in astrocytes, IL-1b requires both the p38 MAPK and
NF-kB pathways to regulate p75
NTR expression; however,
TNF-a regulates p75
NTR only through the NF-kB pathway.
Moreover, TNF-a signalled via the NF-kB pathway to regulate
p75
NTR in both hippocampal neurons and astrocytes, whereas
IL-1b signalled via the p38 MAPK pathway in both cell types
and via NF-kB only in astrocytes.
Cell-surface expression of p75
NTR
p75
NTR is a cell-surface receptor that can bind a variety of
different ligands to mediate distinct cellular functions. To
assess whether the elevated p75
NTR was localized to the cell
surface, biotinylation assays were performed on cytokine-
treated neurons and astrocytes. Nearly all of the detectable
p75
NTR was present at the cell surface after 8 h of treatment
with IL-1b or TNF-a in neurons (Figure 6A) and little p75
NTR
was detected in the intracellular fraction. Similar to neurons,
IL-1b- and TNF-a-treated astrocytes had elevated p75
NTR at
the cell surface, but not in cytosolic compartment
(Figure 6B), suggesting that p75
NTR induced by cytokines is
present at the cell surface in both neurons and astrocytes.
Specificity of the biotin pulldown is shown in Supplementary
Figure S2 (at http://www.asnneuro.org/an/001/an001e
010add.htm).
Figure 2 IL-1 activates p38 MAPK in both neurons and astrocytes, and
NF-kB only in astrocytes
(A) Western blot analysis of p-p38 MAPK activation by IL-1b in neurons.
Hippocampal neurons were cultured for 5 days, and treated with IL-1b for 5,
10, 20, 30 and 60 min and probed for p-p38 MAPK. The blot was stripped and
reprobed for total p38 MAPK (bottom panel). (B) Western blot analysis of p-
IkB in astrocytes. Cultured astrocytes were treated with IL-1b for 5, 10, 20
and 30 min and probed for p-IkB. The blot was stripped and re-probed for
total IkB, which was degraded after phosphorylation (bottom panel). (C)
Hippocampal astrocytes were treated with IL-1b for 5, 10, 20, 30 and 60 min
and probed for p-p38 MAPK. The blot was stripped and reprobed for total p38
MAPK (bottom panel).
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117DISCUSSION
p75
NTR is induced in CNS neurons after many types of injury
(Kokaia et al., 1998; Roux et al., 1999; Casha et al., 2001;
Ramos et al., 2007), and can mediate many different cellular
responses, including neuronal apoptosis or survival, and
regulation of axonal growth (Rabizadeh et al., 1993; Frade et
al., 1996; Maggirwar et al., 1998; Friedman, 2000). However,
the signals that regulate p75
NTR induction in neurons are not
well characterized. Since many different types of pathophy-
siological conditions induce expression of p75
NTR, it is likely
that inflammatory events common to these conditions may
regulate this receptor. A previous study has demonstrated
that hypo-osmotic stress can regulate p75
NTR by increasing
cellular levels of Sp1 in primary cortical neurons (Ramos et al.,
2007). In the present study, we investigated whether the pro-
inflammatory cytokines IL-1b and TNF-a, which are highly
expressed in the brain following injury (Minami et al., 1992;
Taupin et al., 1993; Buttini et al., 1994; Fan et al., 1996;
Eriksson et al., 2000), might play a role in p75
NTR regulation.
Not only are these cytokines highly expressed in the brain
under these pathophysiological conditions, but IL-1 is also
expressed by microglia during neonatal development
(Giulian et al., 1988), a time during which p75
NTR is widely
expressed throughout the brain. Thus this cytokine may
regulate expression of p75
NTR developmentally as well as
after injury.
In addition to the seizure-induced regulation of p75
NTR
that we (Troy et al., 2002) and others (Roux et al., 1999), have
observed in brain neurons, we recently demonstrated that
this receptor is also inducedi na s t r o c y t e sf o l l o w i n g
pilocarpine-induced seizures (Cragnolini et al., 2009). In
astrocytes, we have determined that stimulation of p75
NTR
with NGF negatively regulates cell proliferation (Cragnolini et
al., 2009). Thus we investigated the mechanisms that regulate
p75
NTR induction in both primary hippocampal neurons and
astrocytes. We have demonstrated in the present study that
the pro-inflammatory cytokines IL-1b and TNF-a induce
p75
NTR expression in both hippocampal neurons and astro-
cytes. However, the underlying signalling pathways leading to
p75
NTR induction was cytokine- and cell-type-specific.
Whereas IL-1b induced p75
NTR via p38 MAPK in neurons,
and via both p38 MAPK and NF-kB in astrocytes, TNF-a
induced p75
NTR via NF-kB both in neurons and astrocytes.
Thus inflammatory cytokines play a key role in regulating
p75
NTR expression, and the cellular specificity may provide a
possible therapeutic target for CNS diseases.
Mechanisms of IL-1b regulation of p75
NTR
The release of IL-1b after injury elicits diverse effects
including the production of other cytokines and growth
factors, thereby promoting inflammatory activity. We have
shown in the present study that IL-1b induced p75
NTR
expression in primary hippocampal neurons and astrocytes.
Figure 3 Signalling pathways required for IL-1b induction of p75
NTR in hippocampal neurons and astrocytes
(A) Hippocampal neurons were pretreated with SB203580 (10 mM) or SN-50 (10 mM) for 30 min and then 10 ng/ml IL-1b was added
to the culture for 8 h. Western blot analysis was used to assess p75
NTR and actin levels. (B) Quantification of three blots as shown in
(A). * indicates values are significantly different from control, P,0.05; ** indicates IL-1b+SB203580 is significantly different from IL-
1 alone or IL-1b+SN-50, P,0.05. (C and D) IL-1 induces p75
NTR through both the NF-kB and p38 MAPK pathways in astrocytes.
Cultured astrocytes were pretreated for 30 min with the p38 MAPK inhibitor SB203580 (10 mM) or the NF-kB inhibitor SN-50 (10
mM) prior to IL-1b treatment for 8 h. Western blot analysis was used to detect the p75
NTR and actin levels. (D) Quantification of three
blots as shown in (C). * indicates values are significantly different from control, P,0.05; ** indicates IL-1b+SB203580 and IL-1b+SN-
50 are significantly different from IL-1 alone, P,0.05. C, control; SB, SB203580.
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119The increased p75
NTR expression was transient and returned
to baseline by 24 h, which may be due to the actions of IL-
1Ra, the naturally occurring IL-1b receptor antagonist
(Hannum et al., 1990), providing negative feedback. Many
signalling pathways can be activated by IL-1b in different cell
types, including the classic NF-kB pathway, as well as the
JNK, ERK and p38 MAPK pathways (O’Neill, 2002; Dunne and
O’Neill, 2003). We have previously established that hippo-
campal neurons utilize a different signalling pathway
compared with astrocytes (Srinivasan et al., 2004). Although
IL-1b activated NF-kB in astrocytes, it failed to do so in
hippocampal neurons, activating only p38 MAPK signalling
(Srinivasan et al., 2004). Our present study shows that IL-1b
activation of p38 MAPK was necessary for p75
NTR induction
by this cytokine in the hippocampal neurons.
In contrast with neurons, IL-1b activated both the p38
MAPK pathway and the NF-kB pathway in astrocytes.
Pharmacological inhibitors were used to determine which
of these pathways regulated the induction of p75
NTR
expression in astrocytes. Interestingly, inhibition of either
pathway prevented the increase in p75
NTR expression,
indicating that both p38 MAPK signalling and the NF-kB
pathways are required for p75
NTR induction by IL-1b.
Mechanisms of TNF-a regulation of p75
NTR
TNF-a is another major pro-inflammatory cytokine that is
produced in the brain after injury (Taupin et al., 1993; Fan et
al., 1996) and frequently acts synergistically with IL-1b.I n
contrast with the actions of IL-1b, TNF-a activated the NF-kB
pathway in hippocampal neurons, indicated by phosphoryla-
tion of IkB and nuclear translocation of NF-kB, demonstrat-
ing that these two inflammatory cytokines signal via distinct
pathways. Inhibition of NF-kB nuclear translocation with SN-
50 prevented TNF-a-mediated p75
NTR induction in the
hippocampal neurons, confirming that the distinct pathways
activated by the two different cytokines both lead to
induction of p75
NTR.
Figure 5 TNF-a induces p75
NTR via NF-kB in both neurons and astrocytes
(A) Hippocampal neurons were pretreated with SB203580 (10 mM) or SN-50 (10 mM) for 30 min and then 10 ng/ml TNF-a was
provided for 8 h. Western blot analysis was used to assess p75
NTR and actin levels. (B) Quantification of three blots as shown in (A).
* indicates levels are significantly different from control, P,0.05; ** indicates TNFa+SN-50 is significantly different from TNF-a
alone, P,0.05. (C) Hippocampal astrocytes were pretreated with SB203580 (10 mM) or SN-50 (10 mM) for 30 min and then 10 ng/ml
TNFa was added to the culture for 8 h. Western blot analysis was used to assess p75
NTR and actin. (D) Quantification of three blots as
shown in (C). * indicates levels are significantly different from control, P,0.05; ** indicates TNFa+SN-50 is significantly different
from TNF-a alone, P,0.05. SB, SB203580. C, control.
Figure 4 TNF-a phosphorylates IkB in neurons, and both IkB and p38 MAPK in astrocytes
(A) Hippocampal neurons were cultured for 5 days and treated with TNF-a for the times indicated. Lysates were probed for p-IkB,
stripped and re-probed for total IkB. Note the lack of degradation of IkB. (B) Neuronal lysates were probed for p-p38 MAPK, stripped
and re-probed for total p38 MAPK. (C) Quantification of three blots as shown in (A); TNF-a treatment significantly induced p-IkBa t
5 and 10 min, *P,0.05. (D) Quantification of three blots as shown in (B); TNF-a treatment did not induce phosphorylation of p38
MAPK in hippocampal neurons. (E) Neurons were treated with IL-1b or TNF-a for 30 min, fixed and immunostained for p65. Nuclei
were identified with Hoechst labelling. Note the presence of nuclear p65 in TNF-a-, but not IL-1b-, treated neurons. CTRL, control.
(F) Cultured astrocytes were treated with TNF-a for the times indicated. Astrocyte lysates were probed for p-IkB, stripped and re-
probed for total IkB. (G) Astrocyte lysates were probed for p-p38 MAPK, stripped and re-probed for total p38 MAPK. (H) Analysis of
ubiquitinated IkB in astrocytes and neurons. Cells were treated with TNF-a as indicated. Cell lysates were immunoprecipitated (IP) with
anti-IkB and probed for ubiquitin (Ub). Blots were stripped and re-probed for IkB. Note that levels of total IkB decreased over time in the
astrocytes, but not in the neurons. The molecular mass in kDa is indicated on the left-hand side of the blot. WB, Western blot.
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neurons lead to IkB phosphorylation, there was no sub-
sequent ubiquitination and degradation of the protein as
normally seen in astrocytes and other cell types (Verstrepen et
al., 2008). An alternative pathway for activation of NF-kB has
been demonstrated as a MEKK3 (MAPK/ERK kinase kinase 3)-
dependent pathway in which IkB is phosphorylated and
dissociated from NF-kB, but is not degraded (Yao et al., 2007).
Since that is what we have observed in response to TNF-a
treatment of neurons, this pathway is likely to be the one
involved. In astrocytes, TNF-a activated both the NF-kB and
p38 MAPK pathways, similar to the effects of IL-1b. However,
blocking NF-kB nuclear translocation with SN-50 prevented
TNF-a-mediated induction of p75
NTR,w h e r e a st h ep 3 8
inhibitor had no effect, indicating that the NF-kB pathway
mediates p75
NTR induction by TNF-a in both neurons and
astrocytes. This is in contrast with the regulation of p75
NTR by
IL-1b in astrocytes, which required signalling via both the NF-
kB and p38 MAPK pathways. Thus these two key inflammat-
ory cytokines have a common target in regulation of the
p75
NTR, but the mechanisms by which they regulate
expression of this receptor are distinct both in hippocampal
neurons and astrocytes (Figure 7).
Since p75
NTR is a cell-surface receptor that binds a variety
of ligands to mediate different cellular effects, it was
important to determine whether the inflammatory cytokines
not only increased expression of this receptor in the neurons
and astrocytes, but whether the elevated receptor was on the
cell surface where it may be activated by ligand. Biotinylation
experiments determined that the increased p75
NTR expression
was nearly completely present on the cell surface, confirming
that the receptor would be accessible for ligand binding.
The p75
NTR plays an important role in neuronal apoptosis,
serving as a receptor for proneurotrophins that are released
in the hippocampus following seizures (Volosin et al., 2008).
Thus understanding the mechanisms that regulate expression
of this receptor may serve as a potential therapeutic target
for neuroprotection following seizures or other injuries. There
has been contradictory data on the effect of direct
administration of IL-1b to the rat brain. Whereas one group
has shown that IL-1b and TNF-a administration caused
neuronal loss in the substantia nigra (Carvey et al., 2005),
most studies have shown that IL-1b alone did not directly
affect healthy neurons either in vitro or in vivo (Chao et al.,
1995; Lawrence et al., 1998). However, IL-1 is known to
exacerbate neuronal degeneration, and the naturally occur-
ring IL-1Ra has been shown to be neuroprotective in models
of ischaemia and excitotoxicity (Simi et al., 2007). The
neuronal induction of p75
NTR by inflammatory cytokines may
contribute to neurodegeneration in these pathological
conditions.
Our recent studies have demonstrated that p75
NTR is
induced in hippocampal astrocytes as well as neurons, and
serves to attenuate proliferation of these cells (Cragnolini et
al, 2009). Since excessive glial proliferation can lead to
scarring and inhibition of the potential for regeneration, the
induction of p75
NTR on astrocytes may be beneficial. Thus it
may be therapeutically beneficial to inhibit p75
NTR induction
in hippocampal neurons to prevent neuronal loss, yet permit
p75
NTR induction in astrocytes to attenuate glial proliferation.
The distinct mechanisms of cytokine-mediated p75
NTR
regulation that we have identified in the present study may
facilitate the cell-type-specific regulation of this receptor
and the functional consequences.
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Figure 6 Increased p75
NTR expression induced by IL-1b and TNF-a is
present on the cell surface in both neurons and astrocytes
Cultured hippocampal neurons (A) or astrocytes (B) were treated with IL-1b
or TNF-a for 8 h, and incubated with biotin for 1 h. Cell lysates were
precipitated with streptavidin. Biotinylated cell-surface protein and non-
biotinylated intracellular proteins were analysed by Western blotting for
p75
NTR. Blots were stripped and re-probed for actin, which was only present
in the intracellular fraction. CTRL, control.
Figure 7 Schematic diagram showing the signalling pathways activated by
IL-1b and TNF-a in neurons (red) and astrocytes (black) leading to
induction of p75
NTR.
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